A phase 1b open-label, multicenter study of inhaled DV281, a TLR9 agonist, in combination with nivolumab in patients with advanced or metastatic non-small cell lung cancer

2021 ◽  
pp. clincanres.0263.2021
Author(s):  
Edward B. Garon ◽  
Alexander I. Spira ◽  
Melissa Johnson ◽  
Lyudmila Bazhenova ◽  
Joseph Leach ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Multicenter Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Tlr9 Agonist ◽  
Phase 1B

scholarly journals A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancer

Oncotarget ◽  
2016 ◽  
Vol 8 (9) ◽  
pp. 15924-15933 ◽  
Author(s):  
Antonin Levy ◽  
Etienne Bardet ◽  
Benjamin Lacas ◽  
Jean-Pierre Pignon ◽  
Julien Adam ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Multicenter Study ◽  
Small Cell ◽  
Stage Iii ◽  
Small Cell Lung ◽  
Open Label

scholarly journals Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non–Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study

2020 ◽  
Vol 15 (3) ◽  
pp. 392-403 ◽  
Author(s):  
Enriqueta Felip ◽  
Filippo G. de Braud ◽  
Michela Maur ◽  
Herbert H. Loong ◽  
Alice Tsang Shaw ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Multicenter Phase ◽  
Phase 1B

scholarly journals ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial

2018 ◽  
Vol 19 (5) ◽  
pp. 694-704 ◽  
Author(s):  
John M Wrangle ◽  
Vamsidhar Velcheti ◽  
Manish R Patel ◽  
Elizabeth Garrett-Mayer ◽  
Elizabeth G Hill ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Open Label Phase ◽  
Phase 1B

An open-label, phase 1b study of NEO-PV-01 with pembrolizumab plus chemotherapy in patients with advanced or metastatic nonsquamous non-small cell lung cancer.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. TPS3134-TPS3134
Author(s):  
Ramaswamy Govindan ◽  
Mark M. Awad ◽  
Lisa D Cleary ◽  
Melissa Ann Moles ◽  
Richard Gaynor ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Open Label Phase ◽  
Phase 1B
Sign in / Sign up

Export Citation Format

Share Document